USAN Council

USAN Council,

n.pr the United States Adopted Names Council, responsible for the selection of appropriate nonproprietary names for drugs used in the United States.
Enlarge picture
Urticaria.
References in periodicals archive ?
WHOs INN Expert Group and the USAN Council approve simple, informative and unique nonproprietary names, also known as generic names, for drugs to allow for clear communication among health professionals and to identify chemical/pharmacological relationships.
The USAN Council selects a particular generic name for a new chemical entity with therapeutic potential.
A shorter and easy to remember name is given by the innovating company in consultation with USAN council and must be approved by FDA in USA.
The tongue-twisting words the USAN Council creates are products of "stems" that describe a drug's characteristics, which Drahl likens to the Latin and Greek roots of many English words.
This name was reviewed and accepted by the FDA and USAN Council and will be used by us and our collaborators going forward.
The USAN Council (tri-sponsored by the American Medical Association (AMA), the United States Pharmacopeia Convention (USP), and the American Pharmacists Association (APhA), aims for global standardization and unification of drug nomenclature and related rules to ensure that drug information is communicated accurately and unambiguously, working closely with the International Nonproprietary Name (INN) program of the World Health Organization, and various national nomenclature groups.
Approval by the USAN Council and WHO formally recognizes melanocortin agonists as a distinct therapeutic class and makes bremelanotide the first melanocortin agonist to have an approved generic name.
The USAN Council serves health professionals in the United States by selecting simple, informative, and unique nonproprietary names for drugs by establishing logical nomenclature classifications based on pharmacological and/or chemical relationships to ensure that drug information is communicated accurately and unambiguously.
The purpose of the USAN Council is to select simple, informative and unique nonproprietary names for drugs based on pharmacological and/or chemical relationship.
Pegloticase became the official generic name for Puricase assigned by the USAN Council replacing the previously used name of PEG-uricase.
Separately, the Company announced that pegloticase has become the official generic name for Puricase assigned by the USAN Council, replacing the previously used name of PEG-uricase.
The USAN Council (tri-sponsored by the American Medial Association (AMA), the United States Pharmacopeial Convention (USP), and the American Pharmacists Association (APhA), aims for global standardization and unification of drug nomenclature and related rules to ensure that drug information is communicated accurately and unambiguously, working closely with the International Nonproprietary Name (INN) Programme of the World Health Organization (WHO), and various national nomenclature groups.